XLXiaoqing Lin

Xiaoqing Lin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xiaoqing Lin has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Improving Operator Depth Vision in Gastrointestinal Endoscopy: A Pilot Study of a New Three‐dimensional Imaging System

    by Xiaoqing Lin, Kohei Ono, Ken Ohata, Etsuko Yamabe, Hidenori Eida, Miyuzen Kanamori, Naoki Tomita, Toshifumi Iida, Susumu Banjoya, Tomoya Kimura, et al.

    Background and aims: Traditional two‐dimensional (2D) gastrointestinal endoscopy lacks depth perception, leading to potential diagnostic errors. This study evaluates a novel software‐based three‐dimensional (3D) endoscopy system that converts 2D images into 3D, compatible with existing endoscopes. Methods: A randomized comparative study was conducted with 32 endoscopists at NTT Medical Center. Participants were assigned to perform snaring tasks using either 2D or 3D imaging in short‐ and long‐distance scenarios. Success rates in first attempts were compared between the two groups. Results: In the long‐distance scenario, the first‐attempt success rate was significantly higher in the 3D group (53.13%) compared to the 2D group (21.88%, p = 0.01). The 3D system provided a notable improvement in depth perception and distance judgment, especially for less experienced endoscopists. No significant difference was observed in the time per attempt between the two groups. Conclusions: The new 3D system enhances depth perception and distance judgment, particularly benefiting less experienced endoscopists.


  • Open Access

    Role of Telemedicine in Inflammatory Bowel Disease: Systematic Review and Meta-analysis of Randomized Controlled Trials

    by Lanlan Pang, Hengyu Liu, Zhidong Liu, Jinyu Tan, Long-Yuan Zhou, Yun Qiu, Xiaoqing Lin, Jinshen He, Xuehua Li, Sinan Lin, et al.

    Background: Telemedicine plays an important role in the management of inflammatory bowel disease (IBD), particularly during a pandemic such as COVID-19. However, the effectiveness and efficiency of telemedicine in managing IBD are unclear. Objective: This systematic review and meta-analysis aimed to compare the impact of telemedicine with that of standard care on the management of IBD. Methods: We systematically searched the PubMed, Cochrane Library, EMBASE, Web of Science, and Scopus databases on April 22, 2020. Randomized controlled trials comparing telemedicine with standard care in patients with IBD were included, while conference abstracts, letters, reviews, laboratory studies, and case reports were excluded. The IBD-specific quality of life (QoL), disease activity, and remission rate in patients with IBD were assessed as primary outcomes, and the number of in-person clinic visits per patient, patient satisfaction, psychological outcome, and medication adherence were assessed as secondary outcomes. Review Manage 5.3 and Stata 15.1 were used for data analysis. Results: A total of 17 randomized controlled trials (2571 participants) were included in this meta-analysis. The telemedicine group had higher IBD-specific QoL than the standard care group (standard mean difference 0.18, 95% CI 0.01 to 0.34; P.03). The number of clinic visits per patient in the telemedicine group was significantly lower than that in the standard care group (standard mean difference −0.71, 95% CI −1.07 to −0.36; P<.001). Subgroup analysis showed that adolescents in the telemedicine group had significantly higher IBD-specific QoL than those in the standard care group (standard mean difference 0.42, 95% CI 0.15 to 0.69; I2=0; P.002), but there was no significant difference between adults in the 2 groups. There were no significant differences in disease activity, remission rate, patient satisfaction, depression, self-efficacy, generic QoL, and medication adherence outcomes between the telemedicine and standard care groups. Conclusions: Telemedicine intervention showed a promising role in improving IBD-specific QoL among adolescents and decreased the number of clinic visits among patients with IBD. Further research is warranted to identify the group of patients with IBD who would most benefit from telemedicine.


  • Open Access

    Thalidomide-induced sinus bradycardia in Crohn’s disease: case report and literature review

    by Menghui Liu, Xiaoqing Lin, Lichun Wang, Yao He, Minhu Chen, Ren Mao

    Thalidomide is effective in inducing and maintaining clinical remission, as well as mucosal healing, in patients with refractory Crohn’s disease (CD). However, long-term use of thalidomide has raised concern because of the high incidence of adverse events. Cardiovascular events induced by thalidomide have been reported in patients with multiple myeloma, amyotrophic lateral sclerosis, and transfusion-dependent refractory anemia. We report here an extremely rare case of sinus bradycardia induced by thalidomide in an adult patient with CD. This patient’s heart rate converted back to a normal sinus rhythm after withdrawal of thalidomide, but recurred after restarting of thalidomide. Cardiac toxicity should be closely monitored when using thalidomide in patients with CD.